Isabel Castrejón

Medicine · Health Sciences

27h-index2.7kcitations266works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(160), Spondyloarthritis Studies and Treatments(65), Systemic Lupus Erythematosus Research(57), Autoimmune and Inflammatory Disorders Research(37), Fibromyalgia and Chronic Fatigue Syndrome Research(34)

Publications266 total

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients
EULAR Rheumatology Open·2026
Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry
Lara D. Veeken·2025
Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study
EULAR Rheumatology Open·2025Open Access
Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Results from the BIOBADASER III Registry
EMJ Rheumatology·2025Open Access
Use of Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis in Spain and Barriers to Implementation: A Delphi Study
Advances in Therapy·2025Open Access
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study
BMC Rheumatology·2025Open Access
POS1281 IMPLEMENTATION OF AN ELECTRONIC PATIENT-REPORTED OUTCOME MEASURES SYSTEM FOR REMOTE MONITORING IN BIOBADASER: A MULTICENTER REGISTRY OF ADVANCED THERAPIES IN RHEUMATOLOGY
Annals of the Rheumatic Diseases·2025Open Access
ABS1150 SEX-BASED DIFFERENCES IN PREDICTORS OF SECUKINUMAB EFFECTIVENESS IN EUROPEAN ROUTINE CARE PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE EuroSpA COLLABORATION
Annals of the Rheumatic Diseases·2025Open Access
ABS0131 GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE STUDY ON DRUG RETENTION AND SAFETY IN BIOLOGIC AND TARGETED SYNTHETIC DMARDs
Annals of the Rheumatic Diseases·2025Open Access
OP0065 Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Data from a Multicenter National Real-World Registry
Annals of the Rheumatic Diseases·2025· 2 citedOpen Access
POS0473 Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis initiating biologics or targeted synthetic DMARDs in routine care: real-world data from BIOBADASER
Annals of the Rheumatic Diseases·2025Open Access
Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry
Arthritis Research & Therapy·2025· 2 citedOpen Access
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry
Reumatología Clínica·2025· 1 cited
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry
Reumatología Clínica (English Edition)·2025
Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis. Data from BIOBADASER III registry
2025Open Access
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
Health Policy·2025Open Access
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseases
Clinical Microbiology and Infection·2025· 2 citedOpen Access
Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the EuroSpA Research Collaboration Network
The Journal of Rheumatology·2025· 3 citedOpen Access
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries
Arthritis Research & Therapy·2025· 3 citedOpen Access
Improving early referrals for inflammatory arthritis through primary care engagement: a quality improvement initiative
Rheumatology Advances in Practice·2025Open Access
page 1 of 14Next →

Frequent Co-authors

Theodore Pincus(21), Loreto Carmona(7), José María Álvaro‐Gracia(7), Natalia Mena‐Vázquez(7), Sara Manrique‐Arija(5), J. Molina Collada(5), Yusuf Yazıcı(5), Kathryn Gibson(4), Martin Bergman(4), Santos Castañeda(4), Javier Narváez(4), Myriam Aburto(4), I. Castellví(4), Esteban Cano-Jiménez(4), Claudia Valenzuela(4), José L. Pablos(3), María Galindo-Izquierdo(3), Miriam Retuerto(3), Ricardo Blanco(3), Miguel Á. González‐Gay(3)